BA
BMRA icon

Bard Associates’s Biomerica BMRA Stock Holding History

Bard Associates’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,250
Closed -$73K – 154
2020
Q2 		$73K Hold
1,250
– – 0.04% 144
2020
Q1 		$72K Hold
1,250
– – 0.05% 141
2019
Q4 		$30K Hold
1,250
– – 0.02% 159
2019
Q3 		$33K Hold
1,250
– – 0.02% 159
2019
Q2 		$26K Hold
1,250
– – 0.01% 160
2019
Q1 		$25K Buy
+1,250
New +$24.4K 0.01% 165

Other funds holding BMRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.61B AUM 35.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Bard Associates's BMRA Position: Q3 2020 in Review

Bard Associates sold out of Biomerica (BMRA) in Q3 2020, closing a stake of 1,250 shares — an estimated $73K sold.

Bard Associates first reported a position in BMRA in Q1 2019 and held it in 6 quarters. The position peaked at $73K in Q2 2020. 26 funds tracked by Wall St. Rank hold BMRA as of Q3 2020.

  • Bard Associates reported no remaining Biomerica position as of Q3 2020 after selling out during the quarter.
  • Bard Associates sold 1,250 Biomerica shares in Q3 2020, an estimated $73K.
  • Bard Associates first reported a position in Biomerica in Q1 2019 and held it in 6 quarters.
  • Bard Associates's Biomerica position peaked at $73K in Q2 2020.
  • 26 funds tracked by Wall St. Rank held Biomerica as of Q3 2020.

Based on Bard Associates's 13F filing for Q3 2020, filed 12 Nov 2020.